Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- CheckyesterdayChange DetectedThe page’s results section has been updated to reflect newly posted trial outcomes, including primary efficacy (ORR) and related response measures based on the mIWG-MRT-ECNM criteria. It also updates the defined secondary endpoint measurements for symptoms, quality of life, and treatment-emergent adverse events, along with associated timeframes and assessment methods.SummaryDifference4%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No visible changes to the study details are shown.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; there are no visible changes to core study content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.